C.Uyemura & Co Ltd
TSE:4966
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
C.Uyemura & Co Ltd
Cash & Cash Equivalents
C.Uyemura & Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C.Uyemura & Co Ltd
TSE:4966
|
Cash & Cash Equivalents
ÂĄ38.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
Nitto Denko Corp
TSE:6988
|
Cash & Cash Equivalents
ÂĄ342.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
JSR Corp
TSE:4185
|
Cash & Cash Equivalents
ÂĄ100.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
Kansai Paint Co Ltd
TSE:4613
|
Cash & Cash Equivalents
ÂĄ76.6B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Nippon Paint Holdings Co Ltd
TSE:4612
|
Cash & Cash Equivalents
ÂĄ280B
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
20%
|
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
Cash & Cash Equivalents
ÂĄ1.7T
|
CAGR 3-Years
25%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
See Also
What is C.Uyemura & Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
38.2B
JPY
Based on the financial report for Mar 31, 2024, C.Uyemura & Co Ltd's Cash & Cash Equivalents amounts to 38.2B JPY.
What is C.Uyemura & Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
6%
Over the last year, the Cash & Cash Equivalents growth was 17%. The average annual Cash & Cash Equivalents growth rates for C.Uyemura & Co Ltd have been 8% over the past three years , 2% over the past five years , and 6% over the past ten years .